未知生产厂商
Energy-activated (light-activated) small molecule. In the study procedure, patients are treated with Ruvidar (TLD-1433) via 1 hour of drug instillation followed by 1 hour of light activation; the drug is activated by light from the study device, the TLC-3200 Medical Laser System, and directly targets bladder cancer cells.
